Floatz logo

DACARBAZINE

Colon Neoplasms

AstraZenecaSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Colon Neoplasms cohort.

Asset / SponsorPhaseRating
azd6244
AstraZeneca
Phase 2BB
Temsirolimus
Vejle Hospital
Phase 2B
gi-6301
ImmunityBio, Inc.
Phase 1/2C

Same molecule, other indications

DACARBAZINE is also rated in:

metastatic melanomaDormant
BBB
Indicative ·
72 / 100
View asset →
cutaneous melanomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →